FDA Breaks New Ground by Authorizing SARS-CoV-2 Tests for Sample Pooling by Glenn S. Demby | Sep 8, 2020 | Articles, Essential, FDA-nir, National Lab Reporter... This content is for Paid Members only.Login Register
Saliva COVID-19 Tests Offer Way Around Nasopharyngeal Swab Shortage Bottlenecks by Glenn S. Demby | Sep 4, 2020 | Articles, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register
HHS Clears the Way for Use of New COVID-19 Tests without FDA Emergency Use Authorization by Glenn S. Demby | Aug 29, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings by Glenn S. Demby | Aug 20, 2020 | Articles, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir... This content is for Paid Members only.Login Register
Battle of the SARS-CoV-2 Antibody Immunoassays: Only One Test Meets Both UK Sensitivity and Specificity Targets by Glenn S. Demby | Aug 12, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.Login Register